Facebook
X
LinkedIn
Forward
Clinical Conversations: Gene Therapy
ACTIVITY DESCRIPTION
This expert interview explores the rapidly evolving role of gene therapy through a practical, clinician‑focused lens. Rather than emphasizing future speculation, the discussion centers on what health care professionals need to know now—how gene-based therapies are entering clinical practice, current understanding of safety and efficacy and the role of clinicians across care settings. By addressing common knowledge gaps between specialists and primary care clinicians and using relatable comparisons to established therapies, the interview highlights the importance of patient education, interdisciplinary communication and timely referral as gene‑based treatments continue to expand.
This activity has been designed to meet the educational needs of nurses, nurse practitioners, pharmacists, pharmacy technicians, PAs, physicians, psychologists and other health care professionals.
At the end of this educational activity, participants should be able to:
- Describe the evolving role of gene therapy and gene editing in the management of genetic diseases and recognize the importance of early education, interdisciplinary communication and appropriate referral to support patients who may benefit.
Provided by
This activity is provided by Optum Health Education.
Commercial support
There was no commercial support received for this activity.
Faculty
Haydar A. Frangoul, MD, MS
Medical Director, Pediatric Hematology/Oncology
TriStar Centennia
Haydar A. Frangoul, MD, MS, is a board-certified pediatric hematologist/oncologist and the medical director of pediatric hematology/oncology for the Sarah Cannon Pediatric Transplant and Cellular Therapy Program at TriStar Centennial. He also serves as an investigator for the Sarah Cannon Research Institute, focusing on the research and treatment of blood disorders for pediatric and adult patients, with a specialization in blood and marrow transplantation.
Dr. Frangoul is an internationally recognized expert in stem cell transplantation. He has published more than 130 peer-reviewed manuscripts and presented on more than 35 abstracts. Prior to joining Sarah Cannon and TriStar Health, Dr. Frangoul served as the director of the pediatric stem cell transplant program at Vanderbilt University.
Dr. Frangoul is an adjunct professor at Vanderbilt University and Meharry Medical College. He is also a member of the American Society of Hematology, American Society of Pediatric Hematology/Oncology and the American Society of Bone Marrow Transplant.
When he is not treating patients or conducting research, Dr. Frangoul enjoys traveling, reading, biking, and racquetball.
Planners
Elizabeth Albert, MD
Clinical Manager
Optum Health Education
Sarah Chart, RN
Sr. Director Healthcare Optimization & Strategy
Optum Health Education
Sara L. Fleszar, PharmD, BCOP
Senior Clinical Oncology Pharmacist
Whole Health Solutions
Optum Health
Rebecca Gleason, RN, CCM
Clinical Manager
Optum Health Education
Lisa Latts, MD, MSPH, MBA, FACP
Chief Medical Officer
Optum Behavioral Health Solutions & Optum Health Solutions
Optum Health Clinical Excellence
Optum
Jaime Murillo, MD
Senior Vice President and Chief Medical Officer
Medical Affairs
UnitedHealth Group
Sam Nordberg, PhD
Chair of Psychiatry and Behavioral Health
Optum Massachusetts
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
Financial Relationship Key
A-Advisory Board
CT-Clinical Trial
C-Consultant
E-Employee
G- Grant/Research Support or Funding
I-Stocks and Other Ownership Interests
S-Speakers’ Bureau
O-Other Financial or Material Support
Haydar A. Frangoul, MD has disclosed the following relevant financial relationships: Octa Pharma, Vertex Pharmaceuticals (Consultant) and Jazz Pharmaceuticals (Speakers’ Bureau).
All relevant financial relationships have been mitigated.
The remaining activity faculty or planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
Accreditation statement
In support of improving patient care, this activity has been planned and implemented by Optum Health Education and Optum Health. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit designation statements
This activity was planned by and for the health care team, and learners will receive .25 Interprofessional Continuing Education (IPCE) credits for learning and change.
Physicians
Optum Health Education designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs
The American Academy of PAs (AAPA) accepts credit from organizations accredited by the ACCME.
Pharmacists/Pharmacy technicians
This activity is approved for .25 contact hours (0.025 CEUs) in states that recognize ACPE.
Attending the full program will earn .25 contact hours (0.025 CEUs).
Unique activity number: JA0007123-0000-26-011-H01-P/T
Nurses
The participant will be awarded up to .25 contact hours of credit for attendance and completion of supplemental materials.
Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Psychologists
Optum Health Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. Optum Health Education maintains responsibility for this program. .25 CE hour.
Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
Available Credit
- 0.25 ACPE - Pharmacists
- 0.25 ACPE - Pharmacy Technicians
- 0.25 AMA - Physicians
- 0.25 ANCC - Nurses
- 0.25 APA - Psychologists
- 0.25 Attendance - General Attendance
You must be logged into your account to participate in this activity. Get started by clicking “Register” and following the instructions. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”